| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $738.2M | +24.4% |
| Cost of Revenue | $242.5M | +32.4% |
| Gross Profit | $495.7M | +20.8% |
| R&D Expense | $167.1M | +24.8% |
| SG&A Expense | $146.3M | +26.0% |
| Operating Income | -$144.8M | -18.5% |
| Pre-tax Income | -$128.2M | -27.4% |
| Income Tax | $2.6M | -23.8% |
| Net Income | -$131.3M | -26.6% |
| EPS (Basic) | -$1.22 | -19.6% |
| EPS (Diluted) | -$1.22 | -19.6% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $124.3M | +49.7% |
| Accounts Receivable | $122.3M | +28.5% |
| Current Assets | $567.9M | -11.8% |
| Total Assets | $1.11B | +27.9% |
| Current Liabilities | $420.4M | +29.6% |
| Total Liabilities | $489.6M | +23.6% |
| Stockholders' Equity | $623.8M | +31.4% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $71.4M | +94.8% |
| Capital Expenditures | $9.6M | -27.6% |
| Investing Cash Flow | -$50.9M | -39.6% |
| Financing Cash Flow | $23.0M | +96.3% |
| Free Cash Flow | $61.9M | +163.8% |